AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06577649 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active repetitive transcranial magnetic stimulation (rTMS)
Description: cTBS (50 Hz, 600 pulses, 80% resting motor threshold) for 40s was applied continuously as active rTMS at the face representation area of primary somatosensory cortex (S1)
Study NCT06577649 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham repetitive transcranial magnetic stimulation (sham rTMS)
Description: A sham rTMS was applied using the same stimulation parameters as with cTBS, but using a placebo coil, which produced similar sound as the real coil.
Study NCT04636879 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positive expectation AND dry needling in the upper trapezius fibers, at the most painful point
Description: The subjects will received the same treatment, using dry needling in the upper trapezius fibers, at the most painful point after receiving the corresponding message.
Study NCT04636879 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neutral expectation AND dry needling in the upper trapezius fibers, at the most painful point
Description: The subjects will received the same treatment, using dry needling in the upper trapezius fibers, at the most painful point after receiving the corresponding
Study NCT04636879 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Negative expectation AND dry needling in the upper trapezius fibers, at the most painful point
Description: The subjects will received the same treatment, using dry needling in the upper trapezius fibers, at the most painful point after receiving the corresponding
Study NCT04975932 — intervention group
Intervention type: OTHER
Intervention: TACE+ICIs
Description: TACE plus ICIs ( with or without molecular targeted therapies)
Study NCT04975932 — intervention group
Intervention type: PROCEDURE
Intervention: TACE
Description: TACE without combination of ICIs ( with or without molecular targeted therapies)
Study NCT06176183 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Arthroscopic meniscus repair
Description: A traditional two-portal arthroscopic approach is utilized. The meniscal edges are examined using a probe, and any meniscal tears that are not stable are evaluated for potential repair. For meniscus repair, sutures have been made using the all-inside or outside-inside and inside-outside techniques.~If the procedure involving the addition of a fibrin clot is being carried out, a volume of approximately 60 milliliters of blood is taken and thereafter transferred into a basin. An assistant is able to stir the blood using a glass syringe for approximately fifteen minutes to ensure sufficient coagulation surrounding the syringe. After a sufficient clot has developed at the end of the syringe, a grasper is used to insert the clot through the anterolateral arthroscopy portal. The meniscal sutures are intentionally loosened to accommodate the clot in the meniscus, ensuring optimal contact with the lesion. Subsequently, the sutures are fastened and knotted.
Study NCT05907161 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SRP+LASER (Dentsply Sirona - SIROLaser Blue)
Description: adjunct irradiation with a diode laser (Dentsply Sirona - SIROLaser Blue) intrasulcularly to all sites with PD ≥ 4mm
Study NCT05907161 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SRP+HA
Description: adjunct hyaluronic acid (Regedent, HyaDENT Cross linked hyaluronic intrasulcularly to all sites with PD ≥ 4mm
Study NCT05907161 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SRP
Description: non-surgical periodontal therapy (SRP) with utrasonic device and curretes
Study NCT04734275 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5718
Description: Subjects will receive single doses of AZD5718 on 3 occasions, separated by at least 7 days washout, under fasted and fed conditions.
Study NCT04734275 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AZD5718
Description: Subjects will receive single doses of AZD5718 on 3 occasions, separated by at least 7 days washout, under fasted and fed conditions.
Study NCT05729542 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Arthrex Tightrope
Description: High-tensile strength suture syndesmosis repair
Study NCT05729542 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Synthes Fibulink
Description: High-tensile strength suture syndesmosis repair
Study NCT00013000 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Test strategy for implementation guideline
Study NCT05267223 — intervention group
Intervention type: OTHER
Intervention: Semi-structured interviews
Description: Semi-structured interviews with individuals with paraplegia
Study NCT05143216 — intervention group
Intervention type: OTHER
Intervention: Low concentration oxygen group: Room air (0-2Litre Oxygen via Nasal Canula)
Description: Low concentration oxygen group: Room air (0-2Litre Oxygen via Nasal Cannula)
Study NCT05143216 — intervention group
Intervention type: OTHER
Intervention: High concentration oxygen group: Room air (12-15Litre Oxygen via Non-rebreather Mask)
Description: High concentration oxygen group: Room air (12-15Litre Oxygen via Non-rebreather Mask)
Study NCT05563402 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Atalante
Description: Atalante Gait training: Using the Atalante System (self-reliant walking system), participants will be secured with the appropriate sized harness and attached to an overhead body-weight support system. Each session will begin with a 3-5 minute warm-up in the continuous passive mode (cadence \~40-45 steps/minute).
Study NCT05400395 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GNX80
Description: GNX80 oral intake(BID) for 24 weeks
Study NCT05400395 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo oral intake(BID) for 24 weeks
Study NCT05619406 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Riskometer Application
Description: The intervention group participants at baseline will be assessed by installing a riskometer app on their mobile phones to calculate their global stroke risk score. They will be shown their risk scores and the specific risk factors identified through the screening. They will be counselled and supported to manage their risk factors through lifestyle changes and visit their healthcare provider for appropriate care.
Study NCT05619406 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Routine Clinic Therapy
Description: After their assessment by the blinded adjudicator, the controls will visit the study doctor to obtain the routine clinic therapy and then will be allowed to go home.
Study NCT04982978 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PMT Threat Appraisal
Description: The first half of the PMT present video will include narration by Science Insider producer, Benji Jones, including dialogue regarding the risks associated with vaping by Chief Pediatric Pulmonology at the NYU Winthrop Hospital, Dr. Melodi Pirzada, and information on nicotine by the Director of Pediatric Pulmonology at NYU's Langone Hassenfeld Children's Hospital, Dr. Mikhail Kazachkov. The second half of the PMT present video will include personal experiences and narratives by students at the University of Utah with information regarding our current knowledge of vaping health effects through research by Dr. Sean Maddock and Dr. Sean Callahan from the University of Utah to highlight the susceptibility of vaping for a population of young adults in university.
Study NCT04982978 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: General Nutrition and Lifestyle
Description: The first half of the PMT absent video will be presented by the Alliance for Aging Research, including an immersive video design, explaining the impact that nutrition may have as the participants age, reviewed by Dr. Steven Austad and Senior Nutritionist Johanna Dwyer. The second half of the PMT absent video will be presented by TED-Ed with narration by Addison Anderson, including a similar immersive video design, explaining how the food the participants eat may affect our brain and overall health. The nutrition and lifestyle information design will be administered as a control because it provides informative lifestyle choices regarding nutrition that can help promote the participants overall health without having an underlying link to vaping behaviour and its subsequent effect on the status of health.
Study NCT06339203 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Irrisept
Description: 450ml low concentration (0.05%) Chlorhexidine Gluconate (CHG) in 99.95% Sterile Water
Study NCT06339203 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Normal Saline
Description: 450mL
Study NCT04421118 — intervention group
Intervention type: OTHER
Intervention: a non-invasive technology to evaluate hepatic venous pressure gradient and portal pressure gradient
Description: a non-invasive technology to evaluate hepatic venous pressure gradient and portal pressure gradient based on three-dimensional modeling and fluid dynamics simulation
Study NCT04979156 — intervention group
Intervention type: PROCEDURE
Intervention: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
Description: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
Study NCT05655624 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pursed lip Breathing along Mat Pilates
Description: Experimental Group: will be treated with Pursed lip Breathing along Mat Pilates Training.
Study NCT05655624 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pursed lip breathing without Mat Pilates Training
Description: Control Group will be treated pursed lip breathing without Mat Pilates Training
Study NCT05470218 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Meal
Description: Liquid mixed meal with different amounts of protein and leucine
Study NCT06410625 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: FLT PET imaging
Description: Evaluation of response to chemotherapy with FLT PET imaging
Study NCT04739189 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Con : control condition without exercise / rest condition
Description: Control condition without exercise / rest condition. The adolescents will be asked to remain quiet and at rest during the morning and will receive an ad libitum meal at dinner time. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.
Study NCT04739189 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Def-EX : Condition with an exercise-induced energy deficit
Description: Condition with an exercise-induced energy deficit The adolescents will be asked to complete an acute exercise set at 65% of their capacities (cycling) during the afternoon, inducing an energy expenditure of 400 kcal. Dinner will be served ad libitum. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.
Study NCT04739189 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Def-EI : Condition with an energy-restriction energy deficit
Description: Condition with an energy-restriction energy deficit The adolescents will be asked to remain quiet during the whole day (no physical activity). They will receive a calibrated breakfast reduced from 400 kcal compare to their CON and Def-EX conditions. Dinner will be served ad libitum. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.
Study NCT06540248 — intervention group
Intervention type: DEVICE
Intervention: Ialuadapter
Description: minimally invasive syringe device for bladder catherization
Study NCT06304597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imfinzi
Description: Durvalumab is labeled to IRDye-680LT and will be administered in combination with fluorescently labelled nivolumab (Opdivo)
Study NCT06304597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Opdivo
Description: Nivolumab is labeled to IRDye-800CW and will be administered in combination with fluorescently labelled durvalumab (Imfinzi)
Study NCT06331195 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo phytosterol
Description: Placebo of phytosterol, in the same quantity of the active phytosterol.
Study NCT06331195 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo phytosterol
Description: Placebo of phytosterol, in the same quantity of the active phytosterol.
Study NCT06331195 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo krill oil
Description: Placebo of krill oil, in the same quantity of the active krill oil.
Study NCT06331195 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo krill oil
Description: Placebo of krill oil, in the same quantity of the active krill oil.
Study NCT06331195 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Phytosterol
Description: 2g/day will be provided to the participants, aiming to guarantee a minimum of 800mg/day of free phytosterols.
Study NCT06331195 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Krill oil
Description: 2g/day will be provided to the participants, aiming to guarantee a minimum of 400mg/day of eicosapentaenoic (EPA) and docosahexaenoic (DHA) fatty acids.
Study NCT06004492 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: blended learning program
Description: blended learning program: 8 hours of workshops and four months of practical learning on technology platforms.
Study NCT06647875 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Complementary Feeding Education
Description: This training program has been designed in accordance withWHO Guideline for Complementary Feeding of Infants and Young Children 6-23 Months of Age. The training will be delivered both in-person and via tablet, and will be supported by infographics and visuals created using WHO Guideline for Complementary Feeding of Infants and Young Children 6-23 Months of Age and the Basic Information for Families on Child Health and Safety in the First 5 Years booklet published by the Child Health Association, specifically the section on Healthy Eating. At the end of the training, participants will be provided with a booklet containing the Healthy Eating section of the Child Health Association's booklet.
Study NCT06647875 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Complementary Feeding Education
Description: This training program has been designed in accordance withWHO Guideline for Complementary Feeding of Infants and Young Children 6-23 Months of Age. The training will be delivered both in-person and via tablet, and will be supported by infographics and visuals created using WHO Guideline for Complementary Feeding of Infants and Young Children 6-23 Months of Age and the Basic Information for Families on Child Health and Safety in the First 5 Years booklet published by the Child Health Association, specifically the section on Healthy Eating. At the end of the training, participants will be provided with a booklet containing the Healthy Eating section of the Child Health Association's booklet.
Study NCT05673096 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PACT
Description: Paediatric Autism Communication Therapy
Study NCT05673096 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MAU
Description: Management as usual
Study NCT05805085 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens A
Description: Hydrogel Daily Disposable Toric Contact Lens for 15 minutes
Study NCT05805085 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens B
Description: Silicone Hydrogel Daily Disposable Toric Contact Lens for 15 minutes
Study NCT05024981 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Videographic feedback
Description: Twice a week during his classic re-education sessions, the patient will be filmed for 1 minute. After transferring the video to a tablet, he will watch the video once and decide what he wants to correct. During the second viewing, he will analyse his walk, the therapist being present to provide additional information. Finally, the patient will apply his analysis while being filmed and will compare the possible differences between the 2 videos. Depending on the time available, the patient may have to repeat the recordings, analyses and exercises.
Study NCT05024981 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Classic reeducation
Description: The patient will benefit twice a day for 30 minutes from re-education sessions.
Study NCT06648954 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: multisite HD-tDCS
Description: 5-8 MRI compatible electrodes (2 cm diameter) will be placed based on the neuroimaging and computation modelling. The electrodes will be placed inside MRI compatible sponges and affixed to the head using a device matched cap which will be filled with saline to have good contact with the scalp.
Study NCT06648954 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional tDCS
Description: A pair of 25 cm2 rubber electrodes enclosed in saline-soaked sponges and affixed to the head with rubber bands.
Study NCT06648954 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: 5-8 MRI compatible electrodes (2 cm diameter) will be placed based on the neuroimaging and computation modelling. The electrodes will be placed inside MRI compatible sponges and affixed to the head using a device matched cap which will be filled with saline to have good contact with the scalp.
Study NCT05329051 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SCTV01E
Description: intramuscular injection
Study NCT05329051 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Comirnaty
Description: intramuscular injection
Study NCT06055244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amantadine
Description: Subjects will be give amantadine 100 mg twice daily.
Study NCT06055244 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Amantadine
Description: Subjects will be give amantadine 100 mg twice daily.
Study NCT05970016 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TCC1727 tablet
Description: TCC1727 tablet will be administered orally once a day (QD) every morning for 3 days followed by discontinuation for 4 days, and 21 days/cycle on an empty stomach.
Study NCT05406505 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg Tab
Description: patients will receive once daily dapagliflozin 10 mg orally in addition to standard care
Study NCT05406505 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: patients will receive placebo and standard care.
Study NCT06361303 — intervention group
Intervention type: DEVICE
Intervention: SNOO Bassinet
Description: This is a non-interventional, prospective observational and descriptive active surveillance study of a cohort of individuals who have purchased or rented a SNOO for use with their infant.
Study NCT05680506 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education
Description: Pain neuroscience education will be given in form videos,pictures, stories and metaphors for 2 times per week for 4 weeks.
Study NCT05680506 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard Therapy
Description: Hot pack,TENS, Kaltenborn grade 1 and 2 mobilizations, stretchings and lumbar stabilization exercises
Study NCT05680506 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Therapy
Description: Hot pack,TENS, Kaltenborn grade 1 and 2 mobilizations, stretchings and lumbar stabilization exercises
Study NCT04546113 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-guided Bilateral Paravertebral Block performed with a 20 ml injection of ropivacapine 3,75 mg/ml/side
Description: Bilateral injection of 20 ml of Ropivacaïne 3,75 mg/ml/side
Study NCT04546113 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Bilateral Erector Spinae plane Block performed with a 20 ml injection ropivacaine 3,75 mg/ml/side
Description: Bilateral injection of 20 ml of Ropivacaïne 3,75 mg/ml/side
Study NCT05125952 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Viasys Avea Ventilator
Description: Measuring dynamic airway driving pressure and static airway driving pressure during pressure support breath, and static airway driving pressure during a volume control breath. Measuring airway occlusion pressure during pressure support breath.
Study NCT05125952 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Philips Respironics NM3 device
Description: Measuring static airway driving pressure during pressure support breath
Study NCT05125952 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Servo U ventilator
Description: Measuring static airway driving pressure and p0.1 during pressure support breath.
Study NCT05125952 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vyaire SmartCath adult nasogastric tube with Esophageal balloon
Description: Measuring static and dynamic esophageal driving pressure during pressure support breath, and esophogeal pressure change during airway occlusion maneuver.
Study NCT05517824 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: microinsulated needle radiofrequency
Description: A single treatment using a microinsulated needle radiofrequency device
Study NCT05705115 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ringer acetate
Description: Ringer acetate 5 ml/kg.
Study NCT05705115 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lower body negative pressure
Description: Lower body negative pressure, 40 mmHg. Experimental hypovolemia.
Study NCT05705115 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lower body negative pressure
Description: Lower body negative pressure, 40 mmHg. Experimental hypovolemia.